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Introduction:Clinical reports describe patients with Alzheimer’s disease (AD) exhibit-
ing atypical adaptive walking responses to the visual environment; however, there is
limited empirical investigation of such behaviors or factors modulating their expres-
sion. We aim to evaluate effects of lighting-based interventions and clinical presenta-
tion (visual- vs memory-led) on walking function in participants with posterior cortical
atrophy (PCA) and typical AD (tAD).
Methods: Participants with PCA (n = 10), tAD (n = 9), and healthy controls (n = 12)
walked to visible target destinations under different lighting conditions within two
pilot repeated-measures design investigations (Experiment 1: 32 trials per participant;
Experiment 2: 36 trials per participant). Participants walked to destinations with the
floorpath interrupted by shadows varying in spatial extent (Experiment 1: no, medium,
high shadow) or with different localized parts of the environment illuminated (Experi-
ment 2: target, middle, or distractor illuminated). The primary study outcome for both
experimental taskswas completion time; secondary kinematic outcomeswere propor-
tions of steps identified as outliers (Experiment 1) andwalking path directness (Exper-
iment 2).
Results: In Experiment 1, PCA participants overall demonstratedmodest reductions in
time taken to reach destinations when walking to destinations uninterrupted by shad-
ows compared to high shadow conditions (7.1% reduction [95% confidence interval
2.5, 11.5; P = .003]). Experiment 2 found no evidence of differences in task perfor-
mance for different localized lighting conditions in PCA participants overall. Neither
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experiment found evidence of differences in task performance between conditions in
tAD or control participants overall. Completion time in both patient groupswas longer
relative to controls, and longer in PCA relative to tAD groups.
Discussion: Findings represent a quantitative characterization of a clinical phe-
nomenon involving patients misperceiving shadows, implicating dementia-related
cortico-visual impairments. Results contribute to evidence-based design guidelines for
dementia-friendly environments.
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1 BACKGROUND
The visual environment may play an elevated role mediating everyday
function in Alzheimer’s disease (AD) and other dementia syndromes.
This role is corroborated through clinical observationsof patients over-
stepping perceptual variations in flooring, such as patterned carpet-
ing or shadows, or being overly reliant on landmarks or conspicuous
environmental features to support navigation.1–4 Despite the promise
of cost-effective environmental adaptations facilitating patient auton-
omy and safety, repeated calls for high-quality quantitative research in
this area remain largely unmet,2,5,6 and existing studies have given lim-
ited consideration to patient clinical presentation.7
Posterior cortical atrophy (PCA) is the cardinal “visual demen-
tia,” a neurodegenerative syndrome characterized by progressive
cortico-visual impairment and particular involvement of posterior
parietal and occipito-temporal regions.8–11 PCA is most commonly
caused by AD and is often considered the most common atypi-
cal AD presentation.12 PCA patients have relatively spared involve-
ment of medial temporal regions, correspondingly demonstrating
preserved episodic memory in early disease stages.13,14 Cortico-
visual impairments arising in PCA, and to a lesser extent in typ-
ical, amnestic AD (tAD), include visuospatial and visuoperceptual
deficits, diminished depth perception, and restrictions in the effec-
tive visual field.9,15–18 PCA is associated with environmental disori-
entation and has profound implications for independence, safety, and
care considerations.19 At a relatively early stage, PCA patients may be
unable to drive, read, dress independently, or reliably navigate famil-
iar environments despite relatively preserved memory, language, and
insight.20
Environmental adaptations have been recommended to support
individuals living with dementia, particularly for PCA patients and
AD patients with memory and visuospatial presentations.19,21,22 Rec-
ommendations based predominantly on professional guidance include
strategic use of signage, contrast and salient visual features, pat-
terned flooring, glare, and clutter.2,19,23–25 Lighting modulates con-
trast, perceived clutter, and visual saliency, factors particularly influ-
encing object recognition and gaze location in PCA,26,27 and lighting-
based interventions may promote functional outcomes and fall reduc-
tions in patients with all-cause dementia.23,28
Misperception of shadows has been reported in PCA and later-
stage AD19,24 and is associated with hesitation or disorientation
during navigation.4 Correspondingly, approaches to maintain uni-
formity of lighting and minimize shadows have been recommended
in various forms.23,24,29 Use of localized lighting has been proposed
to emphasize stairways, distinguish environmental settings, or act
as orientation cues,29,30 and location-specific lighting to facilitate
navigation has received limited support from one case study.31 How-
ever, previous reviews have noted generally low-quality evidence
regarding environmental design and patient function, contradictory
recommendations for people with dementia and those with sight loss,
and contentious guidance regarding appropriate lighting for people
living with dementia.2,5,23
We evaluated effects of two lighting-based interventions in par-
ticipants with early-stage PCA, tAD, and controls walking to visible
destinations. We hypothesized that restricting shadows interrupting
floorpaths to destinations would facilitate locomotion in mild PCA
characterized by predominant cortico-visual impairment, but not
control ormild, predominantly amnestic tAD groups.We hypothesized
that illuminating localized, task-relevant parts of the environment
(highlighting the intended destination rather than irrelevant environ-
mental features) would facilitate locomotion in patient participants
but not controls. Study outcomes were time taken to reach destina-




Ten PCA patients, 9 tAD patients, and 12 healthy controls were
included. The number of PCA patients was limited owing to the low
prevalence of PCA. PCA and tAD groups fulfilled clinical criteria for
PCA-pure11,32,33 and research criteria for probable AD,34 respectively.
Groups were of comparable age, sex, and height, and patient groups
were of comparable (mild) disease severity based on mean Mini-
Mental State Examination score (Table 1A). Molecular pathology was
available for 5/10 PCA and 4/9 tAD patients; all were consistent with
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AD pathology. Ethical approval was provided by the National Research
Ethics Service Committee London Queen Square; all participants
provided written informed consent. A neuropsychological test battery
was administered to PCA and tAD patients.
2.2 Procedure
The experimental setting was constructed at the Pedestrian Accessi-
bility Movement and Environment Laboratory (PAMELA), University
College London, which simulates real-world settings while controlling
for physical environmental conditions. The setting consisted of a room
(main dimensions: 4.8m[W] x 2m[H] x 3.6m[D]) with an entry corridor
serving as the trial starting position (Figure 1A). Two doors (0.76m[W]
x 2m[H]) were located 20◦ at 4.0m from the starting position. For each
trial, one door was opened at 46◦ to indicate the target destination.
Participants walked to the target from a starting position. Between tri-
als, a blind obscured the view of the room, with participants instructed
to fixate on a fixed point positioned on the center of the blind at eye
level. AnArduino-based system fulfilled the following functions: signal-
ing raising of the blind, recording trial start, and end time at 1000Hz.
Two experiments were carried out; each was intended to explore
effects of different lighting conditions on locomotion to visible destina-
tions. Both experiments were of a repeated-measures design ensuring
an equal number of trials involving eachof the following variables: door
(left, right), lighting position (left, middle, right), and clutter position
(left, right; Figure 1B). Experiment 1 additionally included fixed furni-
ture. These designs resulted in different “room conditions”; room con-
ditions produced three overall shadow/localized lighting conditions for
each experiment:
∙ Experiment 1 (effects of shadow: 32 trials): eight room conditions
produced the following conditions interrupting the floorpath to des-
tinations with shadows varying in spatial extent: high shadow: eight
trials, clutter on same side as target; medium shadow: eight tri-
als, clutter on side opposite target; no shadow: eight trials, clut-
ter on same side as target; eight trials, clutter on side opposite tar-
get (Figure 1C). Participants performed the task four times for each
room condition. The no shadow condition comprised both of the
two clutter/target combinations tomatch those combinations under
medium and high shadow conditions.
∙ Experiment 2 (effects of localized lighting: 36 trials): 12 room condi-
tions, producing the following conditions illuminating localized parts
of the environment: target illuminated: 12 trials; middle illuminated:
12 trials; distractor illuminated: 12 trials. Participants performed the
task three times for each room condition (Figure 1C).
Mean ground illuminance wasmatched between lighting conditions
(Experiment 1: 17 lx; Experiment 2: 40 lx). Lighting position and clutter
conditions were arranged in variants of a Latin square design (Experi-
ment 1: N = 4; Experiment 2: N = 6). To control for order effects, vari-
ants were counterbalanced within participant and assigned randomly
to participants, so that order varied between participants.
HIGHLIGHTS
∙ Perceptual variations in flooring may prompt atypical gait
response in dementia.
∙ This phenomenon and its relation to clinical phenotype is
little understood.
∙ Locomotion was assessed in posterior cortical atrophy
(PCA) and typical Alzheimer’s disease under three shadow
conditions.
∙ Minimizing shadows was associated with faster and less
hesitant locomotion in PCA.
∙ Cortico-visual impairments are implicated in the expres-
sion of atypical gait.
RESEARCH INCONTEXT
1. Systematic review: The authors reviewed the literature
using traditional sources, meeting abstracts, and profes-
sional practice resources. Previous literature particularly
emphasized appropriate lighting in promoting patient
safety, functional independence, and quality of life. How-
ever, existing knowledgewas predicatedonobservational
study and professional guidance rather than empirical
investigation,with limited considerationof clinical pheno-
type.
2. Interpretation: Findings provide evidence for effects of
lighting variability on locomotion in patientswith the pos-
terior cortical atrophy (PCA) phenotype. Consistent with
reports of misperceived shadows, hesitant gait response
in PCAwas associatedwith local lighting variations. Find-
ings support practice recommendations to manage light-
ing variability, in addition to lighting level.
3. Future directions: the manuscript supports the con-
tribution of cortico-visual impairment toward atypical
responses to the environment observed in dementia
patients. Findings emphasize the need to consider clini-
cal phenotype and environmental challenges in demen-
tia care and the increasing field of in-home monitoring
through pervasive technology.
2.3 Study outcomes
Statistical analyses were performed using Stata (v. 14.1). For statistical
tests we reported a two-sided P-value (alpha level: P< .05).
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TABLE 1 Demographic information and neuropsychological scores of patients with PCA and tAD: (A) Demographic information and (B)
neuropsychological raw scores and estimated performance relative to normative datasets of patients with PCA and tAD
(A) Demographic information PCA (N= 10) tAD (N= 9) Control (N= 12)
a
Sex (male:female) 8:2 7:2 8:4
Age 69.5 (62.3, 75.3) 69.0 (62.0, 76.0) 70.5 (65.0, 72.3)
Height (cm) 175.0 (170.2, 180.0) 175.0 (172.0, 178.0) 178.0 (169.8, 179.0)
MMSE
b
(/30) 24.5 (19.0, 28.8) 23.0 (21.0, 25.0) —
Amyloid beta PET/CSF consistent with AD
c
5/5 4/4
Raw Score % patients below 5th%ile
(B) Neuropsychology test Max Score PCA tAD PCA tAD
Background neuropsychology
Short RecognitionMemory Test for words
(joint auditory/visual presentation)
25 20.5 (19.0, 23.3) 18.0 (16.0, 22.0) 10% 44%
Concrete Synonyms test 25 21.0 (21.0, 23.0) 22.5 (20.8, 23.3) 0% 11%
Naming (verbal description) 20 19.0 (19.0, 19.8) 17.0 (16.0, 19.0) 10% 33%
Calculation (GDA
d
) 24 6.5 (0, 10.0) 6.0 (2.0, 14.0) 40% 44%
Spelling (GDST
e
Set B, first 20 items) 20 15.5 (8.0, 19.8) 14.5 (7.0, 20) 20% 11%
Gesture production test 15 13.5 (12.0, 15) 15 (15, 15) — —
Digit span (forward) 12 8.0 (6.3, 9.0) 8.0 (5.0, 10.0) 10% 22%
Max forward 8 6.5 (6.0, 7.0) 7.0 (5.0, 7.0) — -
Digit span (backward) 12 3.5 (2.3, 5.8) 6.0 (4.0, 8.0) 0% 0%





): Snellen 6/9 6/9 6/9 — —
Figure-ground discrimination (VOSP
g
) 20 17.5 (16.3, 18.8) 19.0 (18.0, 19.0) 70% 33%
Visuoperceptual processing
Fragmented letters (VOSP) 20 7.5 (1.3, 13.3) 19.0 (18.0, 20) 100% 11%
h
Visuospatial processing
Dot counting (VOSP) 10 5.0 (3.6, 6.8) 9.0 (8.0, 10) 90% 33%
h
Visual search
ACancellation: Completion time 90s 65.0s (43.8, 90) 28.0s (23.0, 42.0) 80% 56%
ACancellation: Number of letters missed 19 0.5 (0, 4.3) 0 (0, 0) - -
Medians and interquartile ranges are reported for demographic information and neuropsychological raw scores owing to non-normal distribution of some
variables.
Measures are adopted from a standard published cognitive battery.26,37
Abbreviations: AD, Alzheimer’s disease; CSF, cerebrospinal fluid; PCA, posterior cortical atrophy; PET, positron emission tomography; tAD, typical
Alzheimer’s disease.
a
Available cognitive measures (N = 7; Wechsler Abbreviated Scale of Intelligence, Recognition memory test for words, Paired Associate Learning44) and










Cortical Visual Screening Test.42
g
Visual Object and Space Perception Battery.43
h
Chi-square tests indicate evidence of the proportion of patients performing below the 5th%ile differing between PCA and tAD groups (P≤ .01).
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F IGURE 1 Experimental setting, schema, and room and lighting conditions for Experiments 1 and 2. A, Overhead view of the settings
constructed at an accessibility laboratory (Pedestrian AccessibilityMovement Environment Laboratory, University College London). B, Schematic
of the setting; 1—target door positions, 2—moveable clutter positions (Experiment 1: chair; Experiment 2: table), 3—overhead lighting positions,
4—fixed furniture, 5—fixation point, 6—trial starting position. C, Room conditions and corresponding lighting conditions (Experiment 1: high
shadow, medium shadow, no shadow; Experiment 2: target illuminated, middle illuminated, distractor illuminated); figures in square brackets
indicate the number of trials per condition
2.3.1 Primary outcome: Completion time
Completion time was the difference between trial start and end
times. End times were the first point when the target door thresh-
old was crossed. Times were automatically detected for 1981/2090
(94.8%) trials using a Lightgate sensor; the remainder were man-
ually determined owing to the Lightgate sensor not registering
movement (total trials: 43 control, 48 PCA, 18 tAD). For each
experiment, logarithmically (log) transformed completion times were
analyzed using a mixed-effects linear regression model, with fixed
effects for group and room condition plus their interaction, and nested
random effects for participant, and room condition within partici-
pant. Rather than fitting a standard repeated measures model (which
would assume a homogeneous variance structure), we used a mixed
model that allowed the random-effects and within-person residuals
to have different variances in each group. A log transformation was
used to improve the extent to which the normality assumptions made
by the model were satisfied, with hypothesis tests carried out on
this scale. A further advantage of this transformation is that com-
parisons between groups and room conditions can subsequently be
expressed as percentage differences in geometric means after back
transformation.
For each experiment, an overall between-group comparison was
made for log-transformed mean completion times, averaged over all
room conditions. The primary analyses of the shadow/lighting con-
ditions estimated within group comparisons, the experiments being
more highly statistically powered to detect these within-participant
effects than differences between groups. Within each group, linear
combinations of the estimated mean completion times for each room
condition provided estimated mean completion times for the three
shadow/lighting conditions in each experiment (Experiment 1: high
shadow,medium shadow, no shadow; Experiment 2: target illuminated,
middle illuminated, distractor illuminated). A globalWald test assessed
evidence for a difference across the three shadow/lighting conditions
within each group. Only if statistically significant evidence was found
of an overall difference across shadow/lighting conditions were pair-
wise comparisons between conditions carried out usingWald tests. No
adjustments for multiple comparisons were made, but restricting the
analysis to where the overall test was statistically significant reduces
the chance of false positive findings. For Experiment 1, a global Wald
test separately assessed whether there was evidence of an interac-
tion between group and shadow condition. One participant (PCA) was
unable to complete the last 18 trials for Experiment 2 owing to time
constraints.
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2.3.2 Secondary outcomes
Wireless inertial measurement units (IMUs: Xsens MT) recorded feet
kinematics at 75 Hz. For Experiment 1, IMU data were unavailable for
all trials in one participant (PCA) and were unavailable for the last 16
trials for one participant (PCA) owing to depleted IMU battery, and for
one trial for three participants (two PCA, one control). For Experiment
2, IMU data were unavailable for all trials in one participant (PCA), for
the last 18 trials for the participant (PCA) owing to time constraints
(as in Section 2.3.1), for two trials for one participant (control) and for
one trial for two participants (one tAD, one control) owing to recording
error.
Experiment 1: Step time outliers
Disproportionately long step times were considered to repre-
sent hesitations, consistent with previous observational1,4 and
gait investigations.35 Individual step times were calculated using
threshold resultant acceleration values detecting when the foot was
in contact with the floor. First and last step times were excluded
for each trial. Medians of observed person-specific median step
times were calculated for each group, combining data from all
trials irrespective of shadow condition. Outlying long step times
were iteratively identified as follows.35 For each of the three
groups, a three-level linear mixed model was fitted including ran-
dom effects for participant, “room condition within participant,”
and “trial within participant and room condition.” Outliers with
long step times were defined as observations with a standardized
residual >3; these were removed, the model refitted, and outlier
removal repeated until no further outliers were identified. Numbers
of outliers and total numbers of steps per person under each shadow
condition were displayed in bar charts, without formal statistical
analysis.
Experiment 2:Walking path straightness index
Walking paths were estimated using dead reckoning. IMU acceler-
ations were converted to standard coordinates and integrated to
calculate velocity. Velocity drift was corrected based on periods when
feetwere in contactwith the ground, and corrected velocity integrated
to estimate foot position.35 Walking path straightness index (SI) was
calculated as a ratio of the shortest possible path compared to the
length of the path actually taken by a participant, with a range (0–1)
for which 1 indicated maximum straightness.36 As SI is a proportion
(bounded by 0 and 1) we used an empirical logit transformation, which
makes the distributional assumption of normality more plausible by
transforming the (0, 1) interval so that it is unbounded. A logit trans-
formation improved the extent to which the normality assumptions
made by the model were satisfied. Logit-transformed SI values were
analyzed using the same linear regression model used to analyze
completion time (Section 2.3.1). Results on the logit-transformed
scale were back-transformed to provide estimated average SI
values.
3 RESULTS
Table 1B presents neuropsychological scores and estimated perfor-
mance relative to normative datasets for PCA and tAD groups. Over-
all, tAD patients exhibited a predominantly amnesic syndrome, with a
minority showing evidence of cortico-visual impairments. In contrast,
cortico-visual impairments were evident in all PCA patients, particu-
larly on visuoperceptual and visuospatial measures. Visual search per-
formance was inefficient in both patient groups.
3.1 Experiment 1: Effects of shadow
Table 2 shows comparisons of estimated completion times for differ-
ent shadow conditions in PCA, tAD, and control groups. Figures 2 and 3
show step time outliers for participant groups under different shadow
conditions.
3.1.1 Primary outcome: Completion time
Averaged over room conditions, overall task performance was slower
in both the PCA (estimated geometric mean completion time: 9.9 sec-
onds, 95% confidence interval [CI] 8.5, 11.7) and tAD groups (6.7 sec-
onds, 95% CI 5.9, 7.5) relative to the control group (5.5 seconds, 95%
CI 5.1, 5.9), and in the PCA relative to the tAD group. Between-group
differences were statistically significant (pairwise comparisons all P ≤
.004).
Within thePCAgroup, the global test foundevidence (P= .01) for an
overall difference between shadow conditions. This was largely driven
by a statistically significant (P= .003) but relatively modest 7.1% (95%
CI 2.5%, 11.5%) reduction in geometric mean completion times for the
no versus high shadowcondition comparison. Completion times for the
medium shadow condition were intermediate, and not statistically sig-
nificantly different fromthose for either theno (P= .34) or high shadow
(P= .08) conditions (Table 2).
Analogously, global tests of geometric means comparing shadow
conditionswithin the tAD and control groupswere not statistically sig-
nificant (P= .77 and P= .33, respectively); therefore, no pairwise com-
parisons were carried out. Despite the differences between the partic-
ipant groups in the statistical significance of the shadow effect com-
parisons, a global joint test found no evidence that shadow effects dif-
fered overall between participant groups (P = .15), although it should
be noted that this test is not as highly statistically powered as those
investigating effects within individual groups.
3.1.2 Secondary outcome: Step time outliers
Qualitatively, an increased proportion of outliers was observed as par-
ticipants approached the shadow regions for the PCA group relative
to tAD and control groups (Figure 2; Video in supporting information).
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TABLE 2 Experiment 1: Effects of shadow on completion time
Primary outcome: Completion time
Geometric mean in seconds
a















PCA (N= 10) 10.4 (8.9, 12.3) 9.9 (8.4, 11.7) 9.7 (8.2, 11.4) P= .01 4.9% (–0.6, 10.0) 7.1% (2.5, 11.5) 2.3% (–2.5, 6.9)
tAD (N= 9) 6.6 (5.9, 7.5) 6.7 (6.0, 7.6) 6.6 (5.9, 7.5) P= .77 –2.1% (-8.9, 4.2) –0.3% (-6.0, 5.1) 1.8% (–3.8, 7.1)
Controls (N= 12) 5.5 (5.1, 5.9) 5.5 (5.1, 5.9) 5.4 (5.1, 5.8) P= .33 0.0% (–1.8, 1.7) 0.9% (–0.6, 2.4) 0.9% (–0.6, 2.4)
Estimated geometric means and percentage reduction in completion time results for PCA, tAD, and control groups.
Abbreviations: PCA, posterior cortical atrophy; tAD, typical Alzheimer’s disease.
a
Geometric mean is the exponentiatedmean of the estimated log transformed completion times.
b
Global test of the null hypothesis that within a participant group there is no difference between completion times under the three shadow conditions.
F IGURE 2 Experiment 1: step time outliers for posterior cortical atrophy, control, and typical Alzheimer’s disease groups under shadow
conditions. Step time outliers were determined using feet-mounted inertial measurement units and overlaid over walking paths. Data are
presented for combined door conditions (left/right). Marker size is proportionate to step time, shadows interrupting floorpaths to destination are
indicated with dotted borders
Combining data from all trials irrespective of shadow condition, medi-
ans of observed person-specific median step times were 0.71 seconds
in PCA (interquartile range [IQR; 0.67, 0.72]), 0.63 seconds in tAD (IQR
[0.57, 0.66]), and 0.58 seconds in controls (IQR [0.54, 0.59]).
Figure 3 displays the total number of steps taken by each partici-
pant in each shadow condition, with the number of step time outliers
shown in red. Because there were 16 no shadow condition trials and
only 8mediumand8 high shadow condition trials per participant, num-
bers of steps and step time outliers in the no shadow condition are
halved toaid visual comparability.Overall, controls typically took fewer
steps than both patient groups, with a total of only six step time out-
liers across all participants and shadow conditions. There was marked
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F IGURE 3 Experiment 1: Number of steps and step time outliers for posterior cortical atrophy, typical Alzheimer’s disease, and control groups
under shadow conditions. Number of steps per participant showing outlier step times. Number of steps and outliers are halved for no shadow
results to take account of having double the number of trials compared tomedium and high shadow.Within group participant results are
presented in the same order for each shadow condition
variability in the numbers of steps, and numbers of outliers, in both
patient groups, with some patients having few or no outliers. Typically
those patients who had outliers (considered hesitant steps) had more
when there were shadows, but this pattern was not universal: one tAD
patient had multiple outliers in the no andmedium shadow conditions,
but none under high shadow. The small numbers of participants, cou-
pled with the heterogeneity in the results seen, meant that no formal
statistical analysis is reported.
3.2 Experiment 2: Effects of localized lighting
Table 3 shows comparisons of estimated completion times andwalking
path SI for different localized lighting conditions in PCA, tAD, and con-
trol groups. Figure S1 in supporting information shows walking paths
for participant groups under different localized lighting conditions.
3.2.1 Primary outcome: Completion time
Averaged over room conditions, overall task performance was slower
in both PCA (estimated geometric mean completion time: 9.1 seconds,
95%CI 7.6, 10.9) and tAD groups (6.6 seconds, 95%CI 5.8, 7.5) relative
to the control group (5.3 seconds, 95% CI 5.0, 5.7), and in the PCA rel-
ative to the tAD group. Between-group differences were statistically
significant (pairwise comparisons all P≤ .003).
Global tests found no evidence within any group for a difference in
completion times between localized lighting conditions (PCA: P = .21;
tAD: P= .91; controls: P= .76).
3.2.2 Secondary outcome: Walking path
straightness index
Medians of observed person-specific median SI were slightly lower in
the PCA (0.95, IQR [0.94, 0.96]) relative to the tAD (0.97, IQR [0.97,
0.98]) and control groups (0.97, IQR [0.97, 0.97]), with observed data
qualitatively suggesting a tendency toward some patients taking indi-
rect routes to destinations (Figure S1).
Global tests found no evidencewithin any group for differences in SI
between localized lighting conditions (Table 3B).
4 DISCUSSION
The current pilot investigation presents empirical evidence of lighting-
based interventions on functional locomotion to visible destinations.
Two tasks assessed effects of lighting variability, while controlling the
overall level of ground illuminance. For both tasks, patient groups took
longer to reach target destinations than controls. Qualitatively, some
patients displayed a tendency to take indirect and/or hesitant routes to
destinations as determined through body kinematic analysis. Cortico-
visual impairments were notably apparent in the PCA group, the only
group to show any evidence of effects of lighting interventions on task
performance.
To perform ecological assessment of a complex behavior, a
repeated-measures, randomized, and counterbalanced design and
detailed kinematic and neuropsychological analyses were used.
Findings support previous proposals of atypical walking adaptation
arising from AD-related cortico-visual impairments, and contribute to
recent evidence on environmental adaptations facilitating functional
locomotion in neurodegenerative disease.37
The first experiment investigated effects of shadows interrupting
floorpaths to destinations. In PCA, but not tAD or control groups,
there was evidence for reduced completion time when limiting shad-
ows interrupting the path. This shadow effect was largely driven by a
statistically significant but modest reduction in geometric mean com-
pletion time for no compared to high shadow conditions; geometric
mean completion time for the medium shadow condition was interme-
diate between these two.
There was considerable variability in the secondary outcome (step
timeoutliers–consideredhesitant steps) in bothpatient groups.Anum-
ber of patients had nohesitations; others took substantiallymore steps
with more outliers relative to controls. While there was an overall





















































































































































































































































































































































































































































































































































































































































































































































































































































































tendency for patients to exhibit more outliers when shadows inter-
rupted floorpaths to destinations, the extent of heterogeneity and
number of patients who did not exhibit outliers precluded formal
assessment of differences between shadow conditions. Qualitative
analysis of detected outliers suggested differing spatial profiles in the
occurrence of hesitant steps between patient groups, likely relating to
the principal differences in group presentation (visual versus memory-
led). Taken altogether, results provide evidence for modest benefits of
minimizing shadows on patient function in the PCA group, though find-
ingsmay be relevant to a proportion of tADpatients exhibiting cortico-
visual impairment.17,38
The second experiment investigated effects of localized lighting
of task-relevant (highlighting the intended destination) versus irrel-
evant environmental features. There were no statistically significant
improvements in any group on primary (completion time) and sec-
ondary (walking path directness) outcome measures when highlight-
ing destinations relative to an irrelevant “distractor” destination. The
lack of evidence supporting beneficial effects of localized lighting on
patient locomotion meant that we were unable to reject the null
hypotheses for this experimental task: that patient task performance
does not differ between localized lighting conditions and that there
would be no difference in the effect of localized lighting between
patient and control groups. Findings did not provide evidence to sup-
port previous suggestions of localized lighting assisting orientation and
navigation,24,30,31 at least within this controlled and relatively simple
environment.
Strengths of the current investigation include patient participants
well characterized in neuropsychological phenotype, sensitive kine-
matic measures, a high number of trials per participant, and a random-
ized and counterbalanced design to control for order effects. Room
conditions were balanced and mean ground illuminance matched
between condition. The step time outlier detection method located
disproportionately long step times for individuals during functional
walking to destinations. This method does not require a gait labora-
tory; future work might investigate constrained gait tasks, community
mobility, and feasibility of evaluating effects of environmental adapta-
tions on gait variability and falls.39
Limitations of this pilot study include the presentation of the clutter
variable being affected by overhead lighting position; this interrelation
precluded independent analysis of lighting and clutter position. To
better meet assumptions underlying statistical methods, completion
time and straightness index outcome measures were log- and logit-
transformed, respectively. While hypothesis testing conducted on
raw versus transformed data is not necessarily equivalent,40 validity
of estimates and hypothesis tests depends on model assumptions
being met. While the mild PCA patient group is of comparable size to
interventional studies of atypical clinical phenotypes closely associ-
ated with AD (eg, logopenic variant41), the current pilot investigation
involved a relatively small number of mostly young-onset patients;
statistical tests and confidence intervals should be interpreted with
caution, with findings requiring replication and validation in larger
samples. Furthermore, whilemolecular or pathophysiological evidence
of AD was available in half of patients, non-AD pathologies cannot
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definitively be ruled out. Factors limiting generalizability of findings
include the unfamiliar experimental setting to control for familiarity
and environmental conditions.
The current study provides evidence of lighting-induced perceptual
changes to the physical environment (restricting shadows) supporting
walking performance in PCA, but not tAD or control groups. Future
work might investigate other syndromes (corticobasal, dysexecutive)
and sensory conditions to further explore the interaction between clin-
ical phenotype and environment. Findings may contribute to compen-
satory approaches tomaximize function in PCA, and encourage consid-
eration of environmental conditions in the expanding field of dementia
and pervasive health care.
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